Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

This real-life study aims to describe and compare the characteristics of patients who do or do not receive speech therapy after a memory consultation. Socio-demographic and medical data from the MEMORA cohort were matched with speech therapy reimbursement data from the French caisse primaire d'assurance maladie. Univariate analyses showed that speech therapy was more frequent in men, in patients with higher or secondary education, in patients suffering from Alzheimer's disease (AD) and having a higher MMSE. The multivariate model showed that only the diagnosis of AD remained strongly associated with the presence of speech therapy. The diagnosis of AD is the characteristic associated with the highest probability of future speech therapy. Female gender, lower level of education and lower cognitive efficiency appear to be associated with a lower probability of speech therapy.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Floriane, D.-C., Frederic, G., Juliette, P., Claire, M., Antoine, G.-C., & Virginie, D. (2025). [Speech therapy after memory consultation: characteristics of patients receiving speech therapy sessions]. Geriatrie et psychologie neuropsychiatrie du vieillissement. https://doi.org/10.1684/pnv.2025.1232

Vancouver

Floriane D.-C, Frederic G, Juliette P, Claire M, Antoine G.-C, Virginie D. [Speech therapy after memory consultation: characteristics of patients receiving speech therapy sessions]. Geriatrie et psychologie neuropsychiatrie du vieillissement. 2025. doi:10.1684/pnv.2025.1232. PMID: 40586175.

BibTeX

@article{floriane2025-40586175,
  author  = {Floriane, Delphin-Combe and Frederic, Gervais and Juliette, Petit and Claire, Moutet and Antoine, Garnier-Crussard and Virginie, Dauphinot},
  title   = {{[Speech therapy after memory consultation: characteristics of patients receiving speech therapy sessions]}},
  journal = {Geriatrie et psychologie neuropsychiatrie du vieillissement},
  year    = {2025},
  doi     = {10.1684/pnv.2025.1232},
  pmid    = {40586175},
  url     = {https://doi.org/10.1684/pnv.2025.1232}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This real-life study found that a diagnosis of Alzheimer's disease was the characteristic most strongly associated with receiving speech therapy after a memory consultation, while female gender, lower education, and lower cognitive efficiency were associated with lower probability of speech therapy. It describes access to speech therapy, not treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 33/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 32 of the 96 points it could be judged on, which is 33 of 100. Total 33 of 100.32 of the 96 points we could judge = 33 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 32 of the 96 points we could judge it on, which is 33 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Geriatrie et psychologie neuropsychiatrie du vieillissement)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Virginie Dauphinot: h-index 26 (OpenAlex, whole career)
Institution's track record 2 / 3 Inserm: institution h-index 1,988 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40586175)
Free to read 0 / 2 Behind a paywall — scores zero
Points 32 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 32 of the 96 points we could judge it on is 33 out of 100.
Total 33 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Related studies in Health systems and care delivery

Also in Health systems and care delivery

172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →